Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Study Initiated to Fight Metastatic Breast Cancer with Innovative Nanoparticles

By BiotechDaily International staff writers
Posted on 10 Feb 2014
A USD 1.3 million grant has been given to an American pharmacy professor to further research a new class of inorganic nanoparticles that target primary cancer, and help control the disease’s metastases and recurrence.

Dr. Wei Lu, the recipient of the US The National Institutes of Health (NIH; Bethesda, MD, USA) grant, is an assistant professor of biomedical and pharmaceutical sciences in the College of Pharmacy at the University of Rhode Island (Kingston, USA), has discovered in his early research efforts that hollow copper sulfide nanoparticles are effective in delivering chemotherapy and heat through a laser that can burn the tumor.

The investigator will be using the four-year NIH grant to further his laboratory research with a focus on breast cancer, the second most frequently diagnosed malignancy in women worldwide. “We are developing a novel cancer therapeutic technology that has several innovative features: biodegradability, multimodality, and simplicity,” said Dr. Lu, who is teaming with pharmacy Prof. Bingfang Yan, a specialist in genetic and environmental factors that combine to control the expression of genes involved in drug response and the cellular switches related to tumor formation. “One nanoparticle can carry hundreds or even thousands of drug molecules to a target like a tumor cell,” he said.

Dr. Lu wants to improve photothermal ablation therapy, a process that uses lasers in cancer treatment. At first, high levels of laser treatments were required to burn and consequently destroy the tumor. Inorganic nanoparticles were introduced, approximately 10 years ago, to this process in animal tests, which provided better absorption of the laser light, generated greater heat, and in turn lowered the laser doses.

However, there are several problems with current nanoparticle-aided photothermal ablation therapy. For example, the current delivery technology does not allow the nanoparticles to be distributed evenly in a tumor, thus the heat generated by the particles is not evenly distributed. As a result, malignancy can continue in the site receiving sub-lethal doses of heat.

Furthermore, some types of nanoparticles, such as gold particles, are difficult for the body to eliminate. “As is the case with surgical removal of a tumor, getting all of the cancer is critical,” Dr. Lu said. “The new nanoparticles provide a three-way punch to the tumor: a more widespread ability in a tumor to distribute heat and burn the tumor, a more efficient and comprehensive way to deliver chemotherapy, and better use of heat to activate the chemotherapeutic agents and immunotherapeutic agents. The new nanotechnology has great potential to eradicate tumors."
 
“Such nanoparticles are introduced intravenously and are absorbed into a tumor,” Dr. Lu concluded. “This study is using near-infrared laser light instead of ultraviolet light or visible light because it penetrates tumor tissue better and has much lower side effects. In addition, these particles are readily degradable in the body, minimizing potential organ toxicity.” 

Related Links:

University of Rhode Island
 


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This micrograph depicts the presence of aerobic Gram-negative Neisseria meningitidis diplococcal bacteria; magnification 1150x (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).

Infection by Meningitis Bacteria Depends on Dimerization State of Certain Host Cell Proteins

A team of molecular microbiologists has untangled the complex three-way interaction between the non-integrin laminin receptor (LAMR1), galectin-3 (Gal-2), and the pathogenic bacterium Neisseria meningitidis.... Read more

Drug Discovery

view channel

Molecule in Green Tea Used as Carrier for Anticancer Proteins

A molecule that is a key ingredient in green tea can be employed as a carrier for anticancer proteins, forming a stable and effective therapeutic nanocomplex. This new discovery could help to construct better drug-delivery systems. Some cancer treatments depend on medication comprising the therapeutic drug and a carrier... Read more

Lab Technologies

view channel
Image: The UC Santa Cruz Ebola Genome Portal contains links to the newly created Ebola browser and to scientific literature on the deadly virus (Photo courtesy of UCSC).

Ebola Genome Browser Now Online to Help Scientists’ Respond to Crisis

A US genomics institute has just released a new Ebola genome browser to help international researchers develop a vaccine and antiserum to help stop the spread of the Ebolavirus. The investigators led... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.